By a News Reporter-Staff News Editor at Energy Weekly News -- EnerVest, Ltd., announced that Phil C. DeLozier has been promoted to Executive Vice President, Business Development. In this capacity he is responsible for all of EnerVest's acquisition and divestiture efforts.
"We have been fortunate to acquire more than $1 billion of oil and gas properties in each of the past four years primarily due to Phil's leadership," said John B. Walker, Chief Executive Officer. "Last year alone Phil oversaw $2.9 billion of transactions."
Before joining EnerVest in 2006, he served as Vice President - Business Development of EOG Resources, Inc. Prior to his employment with EOG Resources, Inc., DeLozier was Manager of Business Development at Tenneco Ventures Corp., Vice President of Land & Acquisitions at McCormick Resources, Inc., and held various leadership positions at Tenneco Oil E&P Co. from 1979 to 1996.
He served as the Houston Regional Director and a member of the Board of Directors of the Independent Petroleum Association of America from 2005 to 2013. In June 2005 he received the IPAA Leadership Award for his industry contributions. In addition, Phil serves on the Board of Directors of the World Affairs Council of Houston, where he was Chairman in 2007, and the Palmer Drug Abuse Program. He is also an active member of the International Association of Petroleum Negotiators, TIPRO and the Texas Alliance of Energy Producers. DeLozier earned a Bachelor of Arts degree from Oklahoma State University
Houston-based EnerVest, founded in 1992, acquires, develops and operates more than 23,000 oil and gas wells in 17 states on behalf of its institutional investors. EnerVest also is the general partner of the general partner of EV Energy Partners, L.P., traded as EVEP on NASDAQ. More information about the company is available at www.enervest.net.
Keywords for this news article include: Energy, Oil & Gas, Oil And Gas, EnerVest Ltd..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC